Fibroblast to myofibroblast transition is enhanced by increased cell density

Area of Science:

• Pulmonary Medicine
• Cell Biology
• Biomedical Engineering

Background:

• Idiopathic pulmonary fibrosis (IPF) is a chronic lung disease characterized by inflammation and excessive extracellular matrix (ECM) deposition.
• Fibroblastic foci in IPF lungs contain activated fibroblasts and myofibroblasts, contributing to disease progression.
• Increased cell density and mechanical confinement within these foci may influence fibroblast behavior.

Purpose of the Study:

• To investigate the role of cell density and mechanical confinement in the fibroblast-to-myofibroblast transition (FMT) in the context of IPF.
• To determine how cell density affects human lung fibroblast (HLF) response to TGF-β1.
• To explore potential therapeutic strategies for reducing IPF burden by modulating cell density.

Main Methods:

• Cultured human lung fibroblasts (HLFs) at varying densities (low, medium, high).
• Assessed fibroblast-to-myofibroblast transition (FMT) by measuring α-SMA expression and collagen deposition.
• Utilized micropillar substrates to apply mechanical confinement and evaluated its effect on FMT.

Main Results:

• Increased cell density significantly enhanced the fibroblast-to-myofibroblast transition (FMT) in response to TGF-β1.
• Mechanical confinement via micropillars did not affect FMT incidence.
• High cell density led to increased α-SMA expression and collagen deposition, characteristic of myofibroblasts, particularly with TGF-β1 stimulation.

Conclusions:

• Cell density is a critical factor influencing fibroblast activation and ECM production in IPF models.
• The observed increase in FMT at high cell densities may be mediated by enhanced OB-cadherin expression.
• Reducing cell density within fibroblastic foci could represent a novel therapeutic approach for managing IPF.